Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients

In a combined cohort of SLE and RA patients without clinical CVD, adjusted QTc length was comparable between HCQ and non-HCQ users, supporting its CV safety in patients with rheumatic diseases.